查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654302

全球全身影像市場：市場規模、佔有率、趨勢分析（按方式、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Whole Body Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Nuclear Imaging), By Application (Oncology, Trauma And Emergency Care, Metastasis Detection), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

全身成像市場規模與趨勢：

預計 2024 年全球全身影像市場規模將達到 295.8 億美元，2025 年至 2030 年的複合年成長率為 5.94%。

推動產業成長的關鍵因素包括快速的技術進步，從而提高診斷的準確性和效率。人們對預防篩檢的認知不斷提高，推動了對疾病早期發現和監測的需求。此外，癌症和心血管疾病等慢性疾病的發生率日益上升，需要先進的診斷影像解決方案。老齡化人口對各種健康狀況的敏感度不斷增加，也是全身成像技術擴大採用以便及時診斷和製定治療計劃的因素。

全身成像系統比局部成像技術更有效，因為它們只需一次掃描就能提供整個身體的全面視野。這樣就無需對特定區域進行多次掃描，從而減少了患者重複檢查的需要，並最大限度地減少了診斷延遲。這些系統在識別癌症等全身性疾病方面特別有效，因為必須評估跨多個器官的轉移。它還有助於檢測局部測試中可能遺漏的異常，例如隱藏的病變、血管疾病和影響多個器官的發炎疾病。

CT 和 MRI 技術的進步提高了成像精度、縮短了掃描時間並增加了患者的舒適度，進一步促進了市場的成長。高解析度成像、人工智慧診斷工具和先進的 3D影像處理功能等創新使得更早、更準確地檢測複雜病理成為可能。此外，CT掃描中輻射劑量的降低和MRI掃描中造影效果的改善使得診斷更加安全、有效，進一步推動了其在廣泛醫療應用中的應用。

癌症、心血管疾病、糖尿病、神經系統疾病等慢性病的發生率不斷上升也是推動全身影像產業成長的主要因素。這些疾病通常需要持續監測和早期檢測才能有效治療，這導致對 CT 和 MRI 等先進成像技術的需求增加。全身影像在慢性疾病的診斷、分期和追蹤進展中發揮著至關重要的作用，能夠及時干預並改善患者預後，從而刺激市場擴張。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3 章全身影像市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 全身影像市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章全身影像市場：按方式的估計和趨勢分析

  • 細分儀表板
  • 全身成像市場的波動
  • 全身影像市場：按方式分類的市場規模預測和趨勢分析（2018-2030 年）
  • 電腦斷層掃描 (CT)
  • 磁振造影（MRI）
  • 核子造影
  • 其他方式

第 5 章全身影像市場：按應用分類的估計和趨勢分析

  • 細分儀表板
  • 全身成像市場波動分析
  • 全身影像市場：按應用分類的市場規模預測和趨勢分析（2018-2030 年）
  • 腫瘤學
  • 創傷與急救醫學
  • 轉移檢測
  • 全身健康檢查

第6章全身影像市場：依最終用途的估計與趨勢分析

  • 細分儀表板
  • 全身成像市場的波動
  • 全身影像市場：按最終用途分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院
  • 診斷影像中心
  • 其他最終用戶

7. 全身影像市場：區域估計和趨勢分析（按技術、應用和最終用途）

  • 各地區市場佔有率（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業市場佔有率分析（2024年）
  • 公司地位分析
  • 公司分類（新興企業、創新者、領導者）
  • 公司簡介
    • GE HealthCare
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • Canon Medical Systems
    • Fujifilm Holdings Corporation
    • Mediso Ltd.
    • NeuroLogica (a subsidiary of Samsung Electronics)
    • United Imaging Healthcare
    • Shimadzu Corporation
Product Code: GVR-4-68040-502-8

Whole Body Imaging Market Size & Trends:

The global whole body imaging market size was valued at USD 29.58 billion in 2024 and is expected to grow at a CAGR of 5.94% from 2025 to 2030. Major factors driving the growth of the industry include rapid technological advancements that enhance diagnostic accuracy and efficiency. Rising awareness of preventive health checkups is fueling demand for early detection and monitoring of diseases. Additionally, the growing prevalence of chronic disorders such as cancer and cardiovascular diseases necessitates advanced imaging solutions. The aging population, being more prone to various health conditions, further contributes to the increased adoption of whole-body imaging technologies for timely diagnosis and treatment planning.

Whole-body imaging systems are more efficient than localized imaging techniques as they offer a comprehensive view of the entire body in a single session. This eliminates the need for multiple scans targeting specific regions, reducing patient exposure to repeated procedures and minimizing diagnostic delays. These systems are particularly effective in identifying systemic diseases such as cancer, where metastatic spread across multiple organs must be assessed. They also aid in detecting abnormalities that might be overlooked in regional scans, such as hidden lesions, vascular conditions, or inflammatory diseases affecting multiple systems.

Technological advancements in CT and MRI are further contributing to market growth as they enhance imaging precision, reduce scan times, and improve patient comfort. Innovations such as high-resolution imaging, AI-powered diagnostic tools, and advanced 3D imaging capabilities enable early and accurate detection of complex conditions. Additionally, reduced radiation doses in CT and improved contrast imaging in MRI ensure safer and more effective diagnostic procedures, further driving their adoption across diverse medical applications.

The increasing prevalence of chronic disorders, such as cancer, cardiovascular diseases, diabetes, and neurological conditions, is also a key factor contributing to the growth of the whole-body imaging industry. As these diseases often require ongoing monitoring and early detection for effective management, the demand for advanced imaging technologies like CT and MRI rises. Whole-body imaging plays a crucial role in diagnosing, staging, and tracking the progression of chronic disorders, allowing for timely interventions and improved patient outcomes, thereby fueling market expansion.

Global Whole Body Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global whole body imaging market report on the basis of modality, application, end-use, and region:

  • Modality Outlook (Revenue, USD Million, 2018 - 2030)
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Imaging
  • Other Modalities
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
  • Trauma & Emergency Care
  • Metastasis Detection
  • Full-Body Health Screenings
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Whole Body Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic diseases requiring comprehensive diagnostic imaging
      • 3.2.1.2. Advancements in imaging technologies
      • 3.2.1.3. Growing demand for early and accurate disease diagnosis
      • 3.2.1.4. Expanding applications of whole-body imaging in oncology, cardiology, and neurology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced whole-body imaging systems
      • 3.2.2.2. Limited reimbursement and insurance coverage
      • 3.2.2.3. Limited availability of skilled healthcare professionals
  • 3.3. Whole Body Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Whole Body Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Whole Body Imaging Modality Market Movement Analysis
  • 4.3. Global Whole Body Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Computed Tomography (CT)
    • 4.4.1. Computed tomography (CT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Magnetic Resonance Imaging (MRI)
    • 4.5.1. Magnetic resonance imaging (MRI) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Nuclear Imaging
    • 4.6.1. Nuclear imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Modalities
    • 4.7.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Whole Body Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Whole Body Imaging Application Market Movement Analysis
  • 5.3. Global Whole Body Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Trauma and Emergency Care
    • 5.5.1. Trauma and emergency care market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Metastasis Detection
    • 5.6.1. Metastasis detection market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Full-Body Health Screenings
    • 5.7.1. Full-body health screenings market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Whole Body Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Whole Body Imaging End Use Market Movement Analysis
  • 6.3. Global Whole Body Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other End Users
    • 6.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Whole Body Imaging Market: Regional Estimates & Trend Analysis By Technology, Application, End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. GE HealthCare
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Koninklijke Philips N.V.
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers AG
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Canon Medical Systems
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Fujifilm Holdings Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso Ltd.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. NeuroLogica (a subsidiary of Samsung Electronics)
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Shimadzu Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5. North America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6. North America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8. U.S. whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9. U.S. whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11. Canada whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12. Canada whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Mexico whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14. Mexico whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15. Mexico whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16. Europe whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17. Europe whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18. Europe whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19. Europe whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. UK whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21. UK whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22. UK whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. Germany whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24. Germany whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25. Germany whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. France whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27. France whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28. France whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Italy whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30. Italy whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31. Italy whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Denmark whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33. Denmark whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34. Denmark whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Sweden whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36. Sweden whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37. Sweden whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Norway whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39. Norway whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40. Norway whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. Japan whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46. Japan whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47. Japan whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. China whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49. China whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50. China whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. India whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52. India whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53. India whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. Australia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55. Australia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56. Australia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. South Korea whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58. South Korea whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59. South Korea whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Thailand whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61. Thailand whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62. Thailand whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63. Latin America whole body imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64. Latin America whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65. Latin America whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66. Latin America whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Brazil whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68. Brazil whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69. Brazil whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71. Argentina whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72. Argentina whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa whole body imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78. South Africa whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79. South Africa whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84. UAE whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85. UAE whole body imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait whole body imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87. Kuwait whole body imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88. Kuwait whole body imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Whole body imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Whole body imaging market driver impact
  • Fig. 19 Whole body imaging market restraint impact
  • Fig. 20 Whole body imaging market: Modality movement analysis
  • Fig. 21 Whole body imaging market: Modality outlook and key takeaways
  • Fig. 22 Computed tomography (CT) market estimates and forecast, 2018 - 2030
  • Fig. 23 Magnetic resonance imaging (MRI) market estimates and forecast, 2018 - 2030
  • Fig. 24 Nuclear imaging market estimates and forecast, 2018 - 2030
  • Fig. 25 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 26 Whole body imaging market: Application movement analysis
  • Fig. 27 Whole body imaging market: Application outlook and key takeaways
  • Fig. 28 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 29 Trauma and emergency care market estimates and forecast, 2018 - 2030
  • Fig. 30 Metastasis detection market estimates and forecast, 2018 - 2030
  • Fig. 31 Full-body health screenings market estimates and forecast, 2018 - 2030
  • Fig. 32 Whole body imaging market: End use movement analysis
  • Fig. 33 Whole body imaging market: End use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 35 Diagnostic imaging centers market estimates and forecast, 2018 - 2030
  • Fig. 36 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 37 Global whole body imaging market: Regional movement analysis
  • Fig. 38 Global whole body imaging market: Regional outlook and key takeaways
  • Fig. 39 North America
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S.
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Mexico
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 47 Europe
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France
  • Fig. 54 France market estimates and forecasts, 2018 - 2030
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 59 Denmark
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 61 Sweden
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China
  • Fig. 68 China market estimates and forecasts, 2018 - 2030
  • Fig. 69 Japan
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 71 India
  • Fig. 72 India market estimates and forecasts, 2018 - 2030
  • Fig. 73 Thailand
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Korea
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Australia
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America
  • Fig. 80 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 81 Brazil
  • Fig. 82 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 83 Argentina
  • Fig. 84 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 85 Middle East and Africa
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players- Whole body imaging market